TTAB Oppositions 91227927
USPTO Oppositions proceeding 91227927, filed 2016-05-17. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91227927 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2016-05-17 |
| Last Activity | 2016-09-21 |
| Days Active | 3651 |
Parties
- Creative Design Investments, LLC — Defendant
- Alaven Pharmaceutical LLC — Plaintiff
Plaintiff Marks
- ANADROL — Alaven Pharmaceutical LLC
Defendant Marks
- ANADROLONE — Creative Design Investments, LLC
Recent Documents
- 2016-09-21: TERMINATED — Status
- 2016-09-21: BD DECISION: DISMISSED W/O PREJ — Decisions
- 2016-09-20: W/DRAW OF APPLICATION W/ CONSENT — Withdrawals
- 2016-08-23: SUSPENDED — Status
- 2016-08-23: STIP TO SUSP PEND SETTL NEGOTIATIONS — Motions
- 2016-06-24: SUSPENDED — Status
- 2016-06-24: STIP TO SUSP PEND SETTL NEGOTIATIONS — Motions
- 2016-05-17: PENDING, INSTITUTED — Status
- 2016-05-17: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2016-05-17: FILED AND FEE — Fees